FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1780453311> ?p ?o ?g. }

• W1780453311 endingPage "739" @default.
• W1780453311 startingPage "727" @default.
• W1780453311 abstract "Glioblastoma (GBM) is the most frequent malignant glioma. Treatment of GBM patients is multimodal with maximum surgical resection, followed by concurrent radiation and chemotherapy with the alkylating drug temozolomide (TMZ). The present study aims to identify genes implicated in the acquired resistance of two human GBM cells of astrocytic origin, T98G and U373, to TMZ. Resistance to TMZ was induced by culturing these cells in vitro for months with incremental TMZ concentrations up to 1 mM. Only partial resistance to TMZ has been achieved and was demonstrated in vivo in immunocompromised mice bearing orthotopic U373 and T98G xenografts. Our data show that long-term treatment of human astroglioma cells with TMZ induces increased expression of facilitative glucose transporter/solute carrier GLUT/SLC2A family members, mainly GLUT-3, and of the AKR1C family of proteins. The latter proteins are phase 1 drug-metabolizing enzymes involved in the maintenance of steroid homeostasis, prostaglandin metabolism, and metabolic activation of polycyclic aromatic hydrocarbons. GLUT-3 has been previously suggested to exert roles in GBM neovascularization processes, and TMZ was found to exert antiangiogenic effects in experimental gliomas. AKR1C1 was previously shown to be associated with oncogenic potential, with proproliferative effects similar to AKR1C3 in the latter case. Both AKR1C1 and AKR1C2 proteins are involved in cancer pro-proliferative cell chemoresistance. Selective targeting of GLUT-3 in GBM and/or AKR1C proteins (by means of jasmonates, for example) could thus delay the acquisition of resistance to TMZ of astroglioma cells in the context of prolonged treatment with this drug." @default.
• W1780453311 created "2016-06-24" @default.
• W1780453311 creator A5010487226 @default.
• W1780453311 creator A5033613763 @default.
• W1780453311 creator A5034698479 @default.
• W1780453311 creator A5038828714 @default.
• W1780453311 creator A5050210411 @default.
• W1780453311 creator A5052532082 @default.
• W1780453311 creator A5062908234 @default.
• W1780453311 creator A5068990419 @default.
• W1780453311 creator A5072869049 @default.
• W1780453311 creator A5085579647 @default.
• W1780453311 creator A5086972127 @default.
• W1780453311 creator A5090217698 @default.
• W1780453311 date "2010-09-01" @default.
• W1780453311 modified "2023-10-16" @default.
• W1780453311 title "Long-term In Vitro Treatment of Human Glioblastoma Cells with Temozolomide Increases Resistance In Vivo through Up-regulation of GLUT Transporter and Aldo-Keto Reductase Enzyme AKR1C Expression" @default.
• W1780453311 cites W1509324307 @default.
• W1780453311 cites W1588148930 @default.
• W1780453311 cites W1970456212 @default.
• W1780453311 cites W1971859682 @default.
• W1780453311 cites W1985657228 @default.
• W1780453311 cites W1987784827 @default.
• W1780453311 cites W1989779591 @default.
• W1780453311 cites W1992435888 @default.
• W1780453311 cites W1993974831 @default.
• W1780453311 cites W1997773537 @default.
• W1780453311 cites W2001166400 @default.
• W1780453311 cites W2001902450 @default.
• W1780453311 cites W2005142336 @default.
• W1780453311 cites W2018819897 @default.
• W1780453311 cites W2033847281 @default.
• W1780453311 cites W2044958267 @default.
• W1780453311 cites W2048678124 @default.
• W1780453311 cites W2058734183 @default.
• W1780453311 cites W2066964642 @default.
• W1780453311 cites W2067511799 @default.
• W1780453311 cites W2070006942 @default.
• W1780453311 cites W2072451938 @default.
• W1780453311 cites W2074379908 @default.
• W1780453311 cites W2078104346 @default.
• W1780453311 cites W2081237419 @default.
• W1780453311 cites W2082445955 @default.
• W1780453311 cites W2084479512 @default.
• W1780453311 cites W2085314493 @default.
• W1780453311 cites W2086833517 @default.
• W1780453311 cites W2089482729 @default.
• W1780453311 cites W2091036037 @default.
• W1780453311 cites W2092016784 @default.
• W1780453311 cites W2096287682 @default.
• W1780453311 cites W2097478662 @default.
• W1780453311 cites W2099551830 @default.
• W1780453311 cites W2105252420 @default.
• W1780453311 cites W2105287398 @default.
• W1780453311 cites W2109531556 @default.
• W1780453311 cites W2114012083 @default.
• W1780453311 cites W2121625674 @default.
• W1780453311 cites W2123151929 @default.
• W1780453311 cites W2130503287 @default.
• W1780453311 cites W2144693486 @default.
• W1780453311 cites W2146107023 @default.
• W1780453311 cites W2151896963 @default.
• W1780453311 cites W2152018605 @default.
• W1780453311 cites W2157842304 @default.
• W1780453311 cites W2158681922 @default.
• W1780453311 cites W2167077512 @default.
• W1780453311 cites W2167414381 @default.
• W1780453311 cites W2171585055 @default.
• W1780453311 cites W2171634952 @default.
• W1780453311 cites W2307117515 @default.
• W1780453311 cites W2338617749 @default.
• W1780453311 cites W304684950 @default.
• W1780453311 doi "https://doi.org/10.1593/neo.10526" @default.
• W1780453311 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2933693" @default.
• W1780453311 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20824049" @default.
• W1780453311 hasPublicationYear "2010" @default.
• W1780453311 type Work @default.
• W1780453311 sameAs 1780453311 @default.
• W1780453311 citedByCount "105" @default.
• W1780453311 countsByYear W17804533112012 @default.
• W1780453311 countsByYear W17804533112013 @default.
• W1780453311 countsByYear W17804533112014 @default.
• W1780453311 countsByYear W17804533112015 @default.
• W1780453311 countsByYear W17804533112016 @default.
• W1780453311 countsByYear W17804533112017 @default.
• W1780453311 countsByYear W17804533112018 @default.
• W1780453311 countsByYear W17804533112019 @default.
• W1780453311 countsByYear W17804533112020 @default.
• W1780453311 countsByYear W17804533112021 @default.
• W1780453311 countsByYear W17804533112022 @default.
• W1780453311 countsByYear W17804533112023 @default.
• W1780453311 crossrefType "journal-article" @default.
• W1780453311 hasAuthorship W1780453311A5010487226 @default.
• W1780453311 hasAuthorship W1780453311A5033613763 @default.
• W1780453311 hasAuthorship W1780453311A5034698479 @default.
• W1780453311 hasAuthorship W1780453311A5038828714 @default.
• W1780453311 hasAuthorship W1780453311A5050210411 @default.
• W1780453311 hasAuthorship W1780453311A5052532082 @default.

• next